ObsEva Competitors and Similar CompaniesClear all
Durect's competitors and similar companies include Amicus Therapeutics.
 Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cupertino, US HQ | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 902% increase | Employees 58415% increase |
Valuation ($) | Valuation ($) 45.3 m | Valuation ($) 3.4 b |
Financial | ||
Revenue (est.) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods $78k (FY, 2024) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit $2m (FY, 2024) | Gross profit $561.3m (FY, 2025) |
Net income | Net income ($8.3m) (FY, 2024) | Net income ($27.1m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 20m | Total funding raised $ 88m |
For sources of this data, please see the company profile
View Company Profiles
Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company